• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: HEMOSPHERE, INC. HERO GRAFT; VASCULAR GRAFT PROSTHESIS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

HEMOSPHERE, INC. HERO GRAFT; VASCULAR GRAFT PROSTHESIS Back to Search Results
Model Number HERO 1001
Device Problem Positioning Problem (3009)
Patient Problem No Code Available (3191)
Event Type  Injury  
Event Description
According to a manuscript, the end stage of dialysis access: femoral graft or hero vascular access device, the patient had a surgical revision of the hero graft.Additional information indicated that the revision was to shorten the hero outflow catheter and reposition it one year after conversion for salvage of standard arteriovenous graft to hero.
 
Manufacturer Narrative
This investigation is currently ongoing.Any additional information will be provided in the follow-up report.
 
Manufacturer Narrative
According to a manuscript, the end stage of dialysis access: femoral graft or hero vascular access device, the patient had a surgical revision of the hero graft.Additional information indicated that the revision was to shorten the hero outflow catheter and reposition it one year after conversion for salvage of standard arteriovenous graft to hero.The manufacturing records for lot 0001512 were reviewed, and it was confirmed that all records were controlled, available for review, and met all specifications per the device master record.The instructions for use lists device migration and vascular graft revision/replacement as a potential complication with the use of the hero graft.A review of the manufacturing records has been performed.There is no indication that an error or deficiency occurred at cryolife.
 
Event Description
According to a manuscript, the end stage of dialysis access: femoral graft or hero vascular access device, the patient had a surgical revision of the hero graft.Additional information indicated that the revision was to shorten the hero outflow catheter and reposition it one year after conversion for salvage of standard arteriovenous graft to hero.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HERO GRAFT
Type of Device
VASCULAR GRAFT PROSTHESIS
Manufacturer (Section D)
HEMOSPHERE, INC.
1655 roberts blvd. nw
kennesaw GA 30144
Manufacturer (Section G)
HEMOSPHERE, INC.
1655 roberts blvd. nw
kennesaw GA 30144
Manufacturer Contact
sandra o'reilly
1655 roberts blvd., nw
kennesaw, GA 30144
7704193355
MDR Report Key4178695
MDR Text Key15328388
Report Number3006945290-2014-00078
Device Sequence Number1
Product Code DSY
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature,Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 09/21/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Model NumberHERO 1001
Device Lot Number0001512
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 06/19/2014
Initial Date FDA Received10/16/2014
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received12/08/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-